Mahamaya Lifesc, a company in the Pesticides & Agrochemicals industry, reported revenue of ₹212 crore and net profit of ₹12 crore for the September 2026 quarter.
Mahamaya Lifesc. (BSE: MAHALIFE) closed at ₹147.60 on 20 Nov 2026, up 26.7% over the past year. Its market capitalisation is ₹345 crore and it trades at 17.5 times earnings.
ncorporated in 2002, Mahamaya Lifesciences Limited is engaged in manufacturing, registration and export of finest crop protection products and bioproducts for crop & soil health management.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.